Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,949-9,960 of 10,661

Drug study icon

CompletedNCT00997984

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

This study is completed in the United States and in Canada. It focuses on ADHD.

In United States

ADHDDrugFrom 6 Years to 12 Years

Countries: United States, Canada
Sponsor: Shire
Condition: ADHD

Drug study icon

CompletedNCT01495169

Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 12 Years to 17 Years

Countries: United States
Sponsor: Vanda Pharmaceuticals
Condition: Bipolarity

Behavioral study icon

CompletedNCT05864612

Tools for Anxiety and Depression Screening in Epilepsy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AnxietyBehavioralOver 18 Years

Countries: United States
Sponsor: Wake Forest University Health Sciences
Condition: Depression, Anxiety

Behavioral study icon

CompletedNCT03703258

Tools for Health and Resilience Implemented After Violence Exposure (Project THRIVE)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: University of Washington
Condition: PTSD

Drug study icon

CompletedNCT04173000

Tools to Improve Medication Continuity in Adolescents With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDOtherFrom 11 Years to 15 Years

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati
Condition: ADHD

Other study type icon

CompletedNCT02737098

TOP Implementation Project

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDOtherFrom 18 Years to 99 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Other study type icon

CompletedNCT01072006

Top-Down Executive Control in Traumatic Brain Injury (TBI), PTSD and Combined

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDObservationalFrom 18 Years to 40 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Behavioral study icon

CompletedNCT03176953

Topiramate and Prolonged Exposure

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD, Addiction

Drug study icon

WithdrawnNCT00988481

Topiramate Augmentation in Eating disorders Partial Responders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Neuropsychiatric Research Institute, Fargo, North Dakota
Condition: Eating disorders

Drug study icon

CompletedNCT00211744

Topiramate Augmentation in the Treatment of OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Montefiore Medical Center
Condition: OCD

Drug study icon

CompletedNCT03120468

Topiramate Augmenting Strategies for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Nassima Ait-Daoud Tiouririne
Condition: Addiction

Drug study icon

TerminatedNCT01408641

Topiramate for Alcohol Use in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 21 Years to 64 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: PTSD, Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.